- Home
- HIMS
as 06-30-2025 2:31pm EST
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 6.0B | IPO Year: | N/A |
| Target Price: | $38.00 | AVG Volume (30 days): | 54.6M |
| Analyst Decision: | Hold | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.68 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.47 - $72.98 | Next Earning Date: | 08-04-2025 |
| Revenue: | $1,784,353,000 | Revenue Growth: | 85.99% |
| Revenue Growth (this year): | 62.41% | Revenue Growth (next year): | 19.85% |
Stock Insider Trading Activity of Hims & Hers Health Inc. (HIMS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Okupe Oluyemi | HIMS | Chief Financial Officer | Jun 23 '25 | Sell | $47.25 | 23,107 | $1,091,766.47 | 63,222 | |
| Dudum Andrew | HIMS | Chief Executive Officer | Jun 13 '25 | Sell | $57.45 | 240,771 | $13,813,792.08 | 268,549 | |
| Boughton Soleil | HIMS | Chief Legal Officer | Jun 13 '25 | Sell | $58.28 | 8,023 | $463,293.80 | 163,309 | |
| Becklund Irene | HIMS | PAO | Jun 13 '25 | Sell | $59.75 | 8,485 | $506,978.75 | 712 | |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 13 '25 | Sell | $59.75 | 17,102 | $1,021,844.50 | 278,654 | |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 10 '25 | Sell | $57.00 | 11,000 | $627,000.00 | 278,654 | |
| Chi Michael | HIMS | Chief Commercial Officer | Jun 5 '25 | Sell | $56.00 | 5,100 | $285,600.00 | 278,654 | |
| Okupe Oluyemi | HIMS | Chief Financial Officer | May 28 '25 | Sell | $52.98 | 11,581 | $613,537.06 | 63,222 | |
| Boughton Soleil | HIMS | Chief Legal Officer | May 27 '25 | Sell | $55.87 | 3,233 | $180,627.71 | 163,309 | |
| Becklund Irene | HIMS | PAO | May 22 '25 | Sell | $53.51 | 5,071 | $271,349.21 | 712 |
Latest Hims & Hers Health Inc. News
HIMS Breaking Stock News: Dive into HIMS Ticker-Specific Updates for Smart Investing
LA Times
3 days ago
Hims & Hers' ugly split with Wegovy maker weighs on the telehealth company's future
Insider Monkey
3 days ago
Novo Nordisk (NVO) Terminates Hims & Hers Partnership Over Wegovy Sales Issues
Insider Monkey
3 days ago
Hims & Hers (HIMS) Rallies 11.76% as CEO Not Backing Down After Novo Nordisk Spat
StockStory
4 days ago
Stocks making big moves this week: Torrid, Provident Financial Services, Bumble, Coinbase, and Hims & Hers Health
Zacks
4 days ago
Reasons to Add Align Technology Stock to Your Portfolio Now
Zacks
4 days ago
Health & Fitness Stocks to Buy as the Wellness Trend Grows
Pharmaceutical Technology
4 days ago
Novo Nordisk teams up with WeightWatchers in latest telehealth push
MT Newswires
4 days ago
Social Buzz: Wallstreetbets Stocks Mostly Advancing Premarket Friday; Nike, Circle Internet Group to Open Higher
Compare HIMS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HIMS Hims & Hers Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.